Home
About
Our Team
Contact
Disclaimer
Search
Newsy Trends
NASDAQ / OTC / PINK SHEETS
Newsy Trends
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
About
Our Team
Contact
Disclaimer
Sign in / Join
23.6
C
Munich
Newsy Trends
NASDAQ / OTC / PINK SHEETS
Thursday, June 1, 2023
type here...
Search
Emerging Markets
Energy & Resources
Featured
Media & Technology
BioPharma
Stocks
Newsy Trends
Emerging Markets
Energy & Resources
Featured
Media & Technology
BioPharma
Stocks
- Advertisement -
TAG
AKBA
BioPharma
Akebia Therapeutics Inc (NASDAQ: AKBA) Heating Up as Auryxia Sales Accelerate & FDA Office of New Drugs (OND) Conducts Final Review on Vadadustat for...
Van Leopold
-
March 6, 2023
Akebia Therapeutics Inc (NASDAQ: AKBA) is an exciting low priced Nasdaq biotech advancing Vadadustat; an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor currently in...
Latest news
Ambitious New CEO Takes Control of Cann American Corp (OTCMKTS: CNNA), Acquires Prodigy Stem Cell, Liberty Health Plus, & Looks to Uplist to OTCQB
May 31, 2023
Lawrence Hardge Goes on Facebook Live Updates on Saudi Deal, New Deals Out of Asia, Lebanon, and Dubai
May 30, 2023
Mullens Saudi Deal Closing on Tuesday According to Lawrence Hardge
May 28, 2023
Mullen Powerful Reversal Northbound as Short Position Hits 34 Million
May 25, 2023
Lawrence Hardge Headed to Saudi Arabia Confirms Mullen Gets 50% of Saudi Deal
May 25, 2023
- Advertisement -
